Risedronate sodium | B3365

Risedronate sodium | B3365

Description: Risedronate (risedronic acid), is an orally administered pyridinyl bisphosphonate that inhibits osteoclast-mediated resorption of bone and modulates bone metabolism in women with postmenopausal osteoporosis. It displays antimalarial activity and also inhibits protein prenylation by preventing the transfer of a farnesyl pyrophosphate group to parasite proteins.

Alternate Name/Synonyms: P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-phosphonic acid, monosodium salt

Appearance: Solid

Formulation:

CAS Number: 115436-72-1

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₇H₁₀NO₇P₂ • Na

Molecular Weight: 305.1

Cell-Permeable?: True

Purity: ≥95%

Solubilities: ~10 mg/ml Other Solvents

Handling: Do not take internally. Wear gloves and mask the product! Avoid contact by all modes of exposure.

Tag Line: A bone resorption inhibitor

MDL Number:

PubChem CID: 4194514

PubChem CID Link: https://pubchem.ncbi.nlm.nih.gov/compound/4194514

SMILES: C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]

InChi: InChI=1S/C7H11NO7P2.Na/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);/q;+1/p-1

InChi Key: DRFDPXKCEWYIAW-UHFFFAOYSA-M

Category: Biochemicals